Relay Therapeutics, Inc. (RLAY)
13.02
-1.92
(-12.88%)
USD |
NASDAQ |
Apr 28, 16:00
13.04
+0.02
(+0.12%)
After-Hours: 20:00
Relay Therapeutics EPS Diluted (Quarterly) : -0.3165 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.5655 |
| Spyre Therapeutics, Inc. | -0.6903 |
| Revolution Medicines, Inc. | -1.855 |
| Celcuity, Inc. | -0.9702 |
| Tango Therapeutics, Inc. | -0.2945 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.89M |
| Revenue (Quarterly) | 7.00M |
| Total Expenses (Quarterly) | 61.89M |
| Enterprise Value | 2.150B |
| Gross Profit Margin (Quarterly) | 91.44% |
| Profit Margin (Quarterly) | -784.1% |
| Earnings Yield | -12.38% |
| Normalized Earnings Yield | -12.38 |